Pneumococcal — Precision Vaccinations

Fact checked by Robert Carlson, MD

Jun 22

2 min read

Late Stage Vaccine Updates Issued by Pfizer

Pfizer announces pneumococcal, meningococcal and RSV clinical trials

woman working in a lab

Respiratory Syncytial Virus (RSV)

Fact checked by Robert Carlson, MD

May 24

5 min read

Pfizer Completes Third Phase Three 20vPnC Vaccine Study

PF-06482077 is a 20-Valent pneumococcal conjugate vaccine candidate (20vPnC) helping protect people from invasive pneumococcal disease and pneumonia

two people playing the guitar at sunset

Fact checked by Robert Carlson, MD

Apr 27

3 min read

$120 Million Financing to Advance MAPS Vaccines

Affinivax ASP3772 vaccine is currently being studied in pneumococcal infection in seniors

grandparents sitting on a bench

Fact checked by Robert Carlson, MD

Mar 18

4 min read

Pneumococcal Conjugate Vaccine Candidate Expected to Meet Licensure Criteria

Adult 20vPnC vaccine candidate indicated for the majority of currently circulating pneumococcal disease

adult jogging on a lonely road

Fact checked by Robert Carlson, MD

Feb 22

3 min read

$3 Million Vaccine Development Awarded To Combat Pneumococcus

VaxNewMo bioconjugation technology for vaccine development gains funding

chemical lab